Hansa Biopharma to Participate in Biotech in Europe Forum
Hansa Biopharma AB CEO Renée Aguiar-Lucander will join the State of the Industry Panel at the 26th Annual Biotech in Europe Forum on October 7, 2026, in Basel, Switzerland. The event focuses on the biotech sector.
Lund, Sweden – October 2, 2026 – Hansa Biopharma AB announced today that its CEO, Renée Aguiar-Lucander, is scheduled to participate in the State of the Industry Panel at the 26th Annual Biotech in Europe Forum. The panel discussion will take place on Wednesday, October 7, at 8:30 AM CEST at the Mövenpick Hotel Basel, Switzerland.
The annual forum gathers key figures from the biotechnology sector to discuss current trends, challenges, and future directions within the industry. Aguiar-Lucander's participation highlights Hansa Biopharma's engagement in broader industry dialogues.
Hansa Biopharma is a biopharmaceutical company focused on developing and commercializing innovative treatments for rare immunological diseases. The company's work aims to address unmet medical needs in specialized therapeutic areas.
Companies interested in meeting with Hansa Biopharma's management during the forum can arrange a meeting by contacting the company directly.